P. Lepage et al., MOTHER-TO-CHILD TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND ITS DETERMINANTS - A COHORT STUDY IN KIGALI, RWANDA, American journal of epidemiology, 137(6), 1993, pp. 589-599
The authors report the results of the first 2 years of follow-up of a
prospective cohort study on the mother-to-child transmission of human
immunodeficiency virus type 1 (HIV-1) and its determinants which start
ed in November 1988 in Kigali, Rwanda. The study sample consists of 21
8 newborns of 215 HIV-1 seropositive women matched to 218 newborns of
216 HIV-1 seronegative women of the same age and parity. They were fol
lowed every 2 weeks during the first 2 years of follow-up. HIV-1 antib
odies were detected by enzyme-linked immunoadsorbent assay and Western
blot at 3-month intervals. Two methods of calculating the mother-to-c
hild transmission rate were used: method 1 combines the information pr
ovided by the persistence of HIV-1 antibodies at 15 months of age in c
hildren born to HIV seropositive mothers and the excess mortality in t
his group compared with the cohort of children born to HIV seronegativ
e mothers; method 2 is a case-by-case evaluation of all the children b
orn to HIV seropositive mothers. A logistic regression model was used
to study the determinants of transmission. The probability of survival
at 24 months of age was 81% (95% confidence interval (CI) 75-86) in c
hildren born to seropositive mothers, compared with 95% (95% Cl 92-98)
in children born to seronegative mothers (p < 0.001). The mother-to-c
hild transmission rate calculated with method 1 was 25.7% (95% Cl 18.8
-32.5). With method 2, the medium estimate was 24.7%. In the multivari
ate analysis, a CD4/CD8 ratio <0.5 was the only maternal factor statis
tically associated with an increased risk of mother-to-child transmiss
ion of HIV-1 (odds ratio = 2.9, 95% Cl 1.2-7.2). The authors findings
present evidence for a higher mother-to-child transmission rate of HIV
-1 in children born in Rwanda than in industrialized countries.